Fortune

Why Wall Street sees a $39,800 pancreatic cancer pill as proof of a much bigger bet

Why Wall Street sees a $39,800 pancreatic cancer pill as proof of a much bigger betWorldPing

Dr. Danish Nagda, a shareholder in the developer, told Fortune it was "incredibly exciting ... maybe half a decade away from the post-cancer era."…

This is a short WorldPing brief. The full report was published by Fortune.

Read the full report at Fortune

Related news

Bitcoin Price Eyes $100K as Prediction Markets, Wall Street Weigh InWorldPing
Bitcoin.com

Bitcoin Price Eyes $100K as Prediction Markets, Wall Street Weigh In

Prediction market traders are throwing millions of dollars behind bitcoin price targets stretching from $50,000 to $150,000, and the money on the board shows just how divided the crowd remains over what comes next.

Brief by WorldPing · Original reporting by Bitcoin.com